Wall Street Breakfast cover image

Australia bans weight loss drug copycats

Wall Street Breakfast

00:00

Introduction

This chapter delves into Australia's ban on replicated weight loss drugs like semi-glutide and churzepitide, leading to a surge in compounded alternatives and impacting companies like Bangosuticals and Hymns and Hearns.

Play episode from 00:00
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app